Aden, Konrad

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

Schreiber, S., Aden, K., Bernardes, J. P., Conrad, C., Tran, F., Höper, H., Volk, V., Mishra, N., Blase, J. I., Nikolaus, S., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseCytokine Signaling Pathways and Interactions

Cited by 259

Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy

Bartsch, K., Knittler, K., Borowski, C., Rudnik, S., Damme, M., Aden, K., Spehlmann, M. E., Frey, N., Saftig, P., Chalaris, A., et al. (2017) · Human Molecular Genetics

interferon and immune responsesDNA Repair Mechanisms

Cited by 196

ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS–STING

Aden, K., Tran, F., Ito, G., Sheibani-Tezerji, R., Lipinski, S., Kuiper, J. W., Tschurtschenthaler, M., Saveljeva, S., Bhattacharyya, J., Häsler, R., et al. (2018) · Journal of Experimental Medicine

Inflammatory Bowel Diseaseinterferon and immune responses

Cited by 167